Ultralife Corporation
ULBI
$5.45
$0.112.06%
| Weiss Ratings | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | B | |||
| Rating Factors | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.08 | |||
| Price History | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -9.47% | |||
| 30-Day Total Return | -29.68% | |||
| 60-Day Total Return | -29.86% | |||
| 90-Day Total Return | -35.20% | |||
| Year to Date Total Return | -26.25% | |||
| 1-Year Total Return | -38.42% | |||
| 2-Year Total Return | 33.25% | |||
| 3-Year Total Return | 0.00% | |||
| 5-Year Total Return | 4.81% | |||
| 52-Week High % Change | -60.12% | |||
| 52-Week Low % Change | 0.66% | |||
| Price | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $13.39 | |||
| 52-Week Low Price | $5.31 | |||
| 52-Week Low Price (Date) | Mar 13, 2025 | |||
| 52-Week High Price (Date) | May 09, 2024 | |||
| Valuation | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 88.79M | |||
| Enterprise Value | 94.22M | |||
| Price/Earnings (TTM) | 9.90 | |||
| Earnings Per Share (TTM) | 0.54 | |||
| Earnings Per Share Growth | 119.63% | |||
| Price/Earnings To Growth | 0.08 | |||
| Price/Sales (TTM) | 0.55 | |||
| Price/Book (Q) | 0.66 | |||
| Enterprise Value/Revenue (TTM) | 0.57 | |||
| Price | $5.45 | |||
| Enterprise Value/EBITDA (TTM) | 5.77 | |||
| Enterprise Value/EBIT | 7.60 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 16.87M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 315 332 7100 | |||
| Address | 2000 Technology Parkway Newark, NY 14513 | |||
| Website | www.ultralifecorporation.com | |||
| Country | United States | |||
| Year Founded | 1990 | |||
| Profitability | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 7.50% | |||
| Profit Margin | 5.44% | |||
| Management Effectiveness | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 4.44% | |||
| Return on Equity | 7.04% | |||
| Income Statement | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 165.15M | |||
| Total Revenue (TTM) | 165.15M | |||
| Revenue Per Share | $9.79 | |||
| Gross Profit (TTM) | 43.12M | |||
| EBITDA (TTM) | 16.33M | |||
| EBIT (TTM) | 12.39M | |||
| Net Income (TTM) | 8.99M | |||
| Net Income Avl. to Common (TTM) | 8.99M | |||
| Total Revenue Growth (Q YOY) | -9.61% | |||
| Earnings Growth (Q YOY) | -78.59% | |||
| EPS Diluted (TTM) | 0.54 | |||
| EPS Diluted Growth (Q YOY) | -80.63% | |||
| Balance Sheet | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 6.77M | |||
| Cash Per Share (Q) | $0.40 | |||
| Total Current Assets (Q) | 86.43M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 134.63M | |||
| Current Ratio (Q) | 3.298 | |||
| Book Value Per Share (Q) | $8.09 | |||
| Total Assets (Q) | 172.44M | |||
| Total Current Liabilities (Q) | 26.20M | |||
| Total Debt (Q) | 12.06M | |||
| Total Liabilities (Q) | 37.81M | |||
| Total Common Equity (Q) | 134.48M | |||
| Cash Flow | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -2.33M | |||
| Cash from Financing (TTM) | -16.12M | |||
| Net Change in Cash (TTM) | -2.53M | |||
| Levered Free Cash Flow (TTM) | 9.15M | |||
| Cash from Operations (TTM) | 16.02M | |||
